Showing results (111-120 of 286) with videos related to
Sort By:
Pageof 29
Frontiers in Medicine|December 26, 2022
Case report: Later onset of NRAS-mutant metastatic melanoma in a patient with a partially-excised giant congenital melanocytic nevusBruno Almeida Costa, Victor Zibara, Vasundhara Singh, et al.The American Journal of Dermatopathology|January 22, 2009
Dermatomyositis: a clinicopathological study of 40 patientsEdward S Smith, James R Hallman, Amena M DeLuca, et al.Journal of Drugs in Dermatology : JDD|January 22, 2015
A single-blinded randomized controlled study to assess the efficacy of twice daily application of sinecatechins 15% ointment when used sequentially with cryotherapy in the treatment of external genital wartsShelbi C Jim On, Rita V Linkner, Madelaine Haddican, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Alum with interleukin-12 augments immunity to a melanoma peptide vaccine: correlation with time to relapse in patients with resected high-risk diseaseOmid Hamid, Jolie C Solomon, Ronald Scotland, et al.Annals of Plastic Surgery|November 23, 2022
High-Quality Lipoaspirate Following 1470-nm Radial Emitting Laser-Assisted LiposuctionEyal Shapira, Lori Plonski, Shaked Menashe, et al.Journal of the American Academy of Dermatology|July 31, 2016
Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort studyGary Goldenberg, Tom Karagiannis, Jacqueline Blanche Palmer, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanomaJeffrey S Weber, Omid Hamid, Scott D Chasalow, et al.JAMA Oncology|January 4, 2019
Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Systematic Review and Meta-analysisChristopher J D Wallis, Mohit Butaney, Raj Satkunasivam, et al.Frontiers in Immunology|January 1, 2025
NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesisKuldeep Makwana, Edwin J Velazquez, Diego M Marzese, et al.Oncoimmunology|March 14, 2013
Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumorsRobert H Vonderheide, Jennifer M Burg, Rosemarie Mick, et al.Pageof 29